Skadden advised Catalent on the transaction. Catalent, Inc. has entered into a definitive agreement to sell its oral solids development and small-scale manufacturing facility in Somerset,...
You must be a Standard 1 Year member to access this content.
Skadden advised Catalent in the transaction. Pace® Life Sciences, LLC, a contract development, and manufacturing organization (CDMO) and a Division of Pace®, a Science and Technology...
You must be a Standard 1 Year member to access this content.
Goodwin Procter and Kromann Reumert are advising Novo Holdings on the transaction, Skadden, Arps, Slate, Meagher & Flom is advising Catalent, Inc. and Jones Day is...
You must be a Standard 1 Year member to access this content.
Skadden advised Mayne Pharma Group Limited in the deal. Fried Frank acted as counsel to Catalent. Mayne Pharma Group Limited has entered into an agreement with Catalent,...
You must be a Standard 1 Year member to access this content.
Fried Frank acted as counsel to Catalent on the deal. Catalent, Inc. (“Catalent”) announced its acquisition of the business and assets of Vaccine Manufacturing and Innovation...
You must be a Standard 1 Year member to access this content.
Fried Frank acted as counsel to Catalent in the deal. Catalent, Inc. executed the issuance of US$650 million aggregate principal amount of 3.500% senior notes due 2030....
You must be a Standard 1 Year member to access this content.
